Show simple item record

dc.contributor.authorHenry, E
dc.contributor.authorAl-Janabi, H
dc.contributor.authorBrouwer, W
dc.contributor.authorCullinan, J
dc.contributor.authorEngel, L
dc.contributor.authorGriffin, S
dc.contributor.authorHulme, C
dc.contributor.authorKingkaew, P
dc.contributor.authorLloyd, A
dc.contributor.authorPayakachat, N
dc.contributor.authorPennington, B
dc.contributor.authorPeña-Longobardo, LM
dc.contributor.authorProsser, LA
dc.contributor.authorShah, K
dc.contributor.authorUngar, WJ
dc.contributor.authorWilkinson, T
dc.contributor.authorWittenberg, E
dc.date.accessioned2024-07-02T13:48:29Z
dc.date.issued2023-12-02
dc.date.updated2024-07-02T10:43:06Z
dc.description.abstractBackground: Omission of family and caregiver health spillovers from the economic evaluation of healthcare interventions remains common practice. When reported, a high degree of methodological inconsistency in incorporating spillovers has been observed. Aim: To promote emerging good practice, this paper from the Spillovers in Health Economic Evaluation and Research (SHEER) task force aims to provide guidance on the incorporation of family and caregiver health spillovers in cost-effectiveness and cost-utility analysis. SHEER also seeks to inform the basis for a spillover research agenda and future practice. Methods: A modified nominal group technique was used to reach consensus on a set of recommendations, representative of the views of participating subject-matter experts. Through the structured discussions of the group, as well as on the basis of evidence identified during a review process, recommendations were proposed and voted upon, with voting being held over two rounds. Results: This report describes 11 consensus recommendations for emerging good practice. SHEER advocates for the incorporation of health spillovers into analyses conducted from a healthcare/health payer perspective, and more generally inclusive perspectives such as a societal perspective. Where possible, spillovers related to displaced/foregone activities should be considered, as should the distributional consequences of inclusion. Time horizons ought to be sufficient to capture all relevant impacts. Currently, the collection of primary spillover data is preferred and clear justification should be provided when using secondary data. Transparency and consistency when reporting on the incorporation of health spillovers are crucial. In addition, given that the evidence base relating to health spillovers remains limited and requires much development, 12 avenues for future research are proposed. Conclusions: Consideration of health spillovers in economic evaluations has been called for by researchers and policymakers alike. Accordingly, it is hoped that the consensus recommendations of SHEER will motivate more widespread incorporation of health spillovers into analyses. The developing nature of spillover research necessitates that this guidance be viewed as an initial roadmap, rather than a strict checklist. Moreover, there is a need for balance between consistency in approach, where valuable in a decision making context, and variation in application, to reflect differing decision maker perspectives and to support innovation.en_GB
dc.description.sponsorshipIrish Research Councilen_GB
dc.description.sponsorshipUniversity of Galwayen_GB
dc.format.extent343-362
dc.format.mediumPrint-Electronic
dc.identifier.citationVol. 42 (3), pp. 343-362en_GB
dc.identifier.doihttps://doi.org/10.1007/s40273-023-01321-3
dc.identifier.grantnumberGOIPG/2021/107en_GB
dc.identifier.urihttp://hdl.handle.net/10871/136541
dc.identifierORCID: 0000-0003-2077-0419 (Hulme, Claire)
dc.language.isoenen_GB
dc.publisherSpringeren_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/38041698en_GB
dc.rights© The Author(s). Open Access. This article is licensed under a Creative Commons Attribution-Non-Commercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en_GB
dc.titleRecommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force.en_GB
dc.typeArticleen_GB
dc.date.available2024-07-02T13:48:29Z
dc.identifier.issn1170-7690
exeter.place-of-publicationNew Zealand
dc.descriptionThis is the final version. Available from Springer via the DOI in this record.en_GB
dc.descriptionAvailability of data and material. All data pertaining to this study are available from the corresponding authors upon reasonable request.en_GB
dc.identifier.eissn1179-2027
dc.identifier.journalPharmacoeconomicsen_GB
dc.relation.ispartofPharmacoeconomics, 42(3)
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en_GB
dcterms.dateAccepted2023-09-28
dc.rights.licenseCC BY-NC
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-12-02
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-07-02T11:18:02Z
refterms.versionFCDVoR
refterms.dateFOA2024-07-02T13:48:37Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-12-02


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s). Open Access. This article is licensed under a Creative Commons Attribution-Non-Commercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Except where otherwise noted, this item's licence is described as © The Author(s). Open Access. This article is licensed under a Creative Commons Attribution-Non-Commercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.